Myriad Genetics, Inc. logo

Myriad Genetics, Inc.

NASDAQ:MYGN

Overview | Financials
Company Name Myriad Genetics, Inc.
Symbol MYGN
Currency USD
Price 17.67
Market Cap 1,604,796,468
Dividend Yield 0%
52-week-range 16 - 29.3
Industry Diagnostics & Research
Sector Healthcare
CEO Mr. Paul J. Diaz
Website https://myriad.com

An error occurred while fetching data.

About Myriad Genetics, Inc.

Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the

Related Stocks

Ironwood Pharmaceuticals, Inc. logo

Ironwood Pharmaceuticals, Inc.

IRWD

4.66 USD

PROCEPT BioRobotics Corporation logo

PROCEPT BioRobotics Corporation

PRCT

96.23 USD

Schrödinger, Inc. logo

Schrödinger, Inc.

SDGR

18.78 USD

LumiraDx Limited logo

LumiraDx Limited

LMDX

0.016 USD

Definitive Healthcare Corp. logo

Definitive Healthcare Corp.

DH

4.31 USD

Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc.

RLAY

6.14 USD

Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc.

FLGT

22.02 USD

Financials

Numbers are in millions USD

Numbers are in millions USD